Baxter International Inc
Change company Symbol lookup
Select an option...
BAX Baxter International Inc
CLXPF Cybin Inc
RVVTF Revive Therapeutics Ltd
SHRMF Braxia Scientific Corp
LKYSF Numinus Wellness Inc
MNMD Mind Medicine (MindMed) Inc
CMPS Compass Pathways PLC
TLIS Talis Biomedical Corp
DVN Devon Energy Corp
BCX BlackRock Resources & Commodities Strategy Trust

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Day's Change
-2.65 (-3.06%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 2,887,014 shares is on pace to be much greater than BAX's 10-day average volume of 2,417,105 shares.


Upcoming Events

BAX's fiscal year ends in December
    • JUN
    • Ex-dividend Date
    • Dividend amount
    • Record date
      June 4, 2021
    • Pay date
      July 1, 2021

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
April 29, 2021Q1 2021 Earnings Release$0.76$0.632 to $0.68$0.82
February 4, 2021Q4 2020 Earnings Release$0.80$0.728 to $0.79$0.97
October 29, 2020Q3 2020 Earnings Release$0.83$0.69 to $0.76$0.74
July 30, 2020Q2 2020 Earnings Release$0.64$0.63 to $0.816$0.84

Past Dividends

Ex-dividend dateAmountRecord datePay date
February 25, 2021$0.245February 26, 2021April 1, 2021
December 3, 2020$0.245December 4, 2020January 4, 2021
August 28, 2020$0.245August 31, 2020October 1, 2020
June 4, 2020$0.245June 5, 2020July 1, 2020

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.